Explore FHI 360

77 Results Found

  • Feature
    Markus Steiner and Kate Rademacher of FHI 360 discuss the long-term effort to increase global access to contraceptive implants at an affordable price.
  • Feature
    In Nigeria, the Akwa Ibom AIDS Indicator Survey (AKAIS) generated more accurate data than previously available. The data will be used to improve Akwa Ibom State’s response to HIV.
  • Published research
    A measurement error model approach to survey data integration: Combining information from two surveys
    Combining information from two surveys is a challenge in survey sampling, particularly when there are overlapping geographies. In such cases, dual frame estimation methods are employed to derive overall estimates while avoiding double contributions coming from the overlap area. In this paper, measurement error models were layered onto the dual frame approach, to appropriately account for potential measurement errors. The approach can be generalized to combine more than two sources of information.
  • Published research
    Comparing focus groups and individual interviews: Findings from a randomized study
    Researchers often question using focus groups or individual interviews for their studies. The findings in this article are based on a randomized study in which data from focus groups and individual interviews were compared. The authors found that sensitive and personal disclosures were more likely in a focus group and some sensitive themes only occurred in a focus group. The authors suggest these findings can help researchers align qualitative data collections methods with study objectives.
  • News
    FHI 360 is providing monitoring services for a trial to evaluate a DNA vaccine for the Zika virus, which could protect healthy adults and adolescents.
  • Published research
    Safety and tolerability of maraviroc-containing regimens to prevent HIV infection in women: A phase 2 randomized trial
    This study shows that, for U.S. women at risk of HIV infection, pre-exposure prophylaxis (PrEP) regimens containing maraviroc are safe and well-tolerated, compared with the standard regimen of tenofovir disoproxil fumarate/emtricitabine. The authors also found that no new infections occurred with the study regimen, compared with the standard regimen, but more research is needed to determine whether that outcome is because of the study drug and whether the enrolled population was lower risk than anticipated.
  • Published research
    HIV treatment cascade among female entertainment and sex workers in Cambodia: Impact of amphetamine use and an HIV prevention program
    This study examines the continuum-of-care outcomes among HIV-positive, female, entertainment sex workers in Cambodia. While most women were successfully linked to HIV care, the authors found that retention and viral suppression were low. The authors suggest that tailored existing HIV/AIDS prevention programs that target the broader population of HIV-positive, female, entertainment sex workers, as well as interventions to reduce amphetamine-type stimulant use, could optimize the health benefits of HIV treatment.
  • Published research
    Real-time monitoring through the use of technology to enhance performances throughout HIV cascades
    The authors found numerous publications documenting uses of technology at various stages of the HIV prevention-to-treatment cascade. But, they noted a lack of evidence on technology to track and improve services across the entire cascade. This review highlights lessons learned from a range of technical solutions for HIV services. The paper will inform successful real-time program monitoring.
  • Published research
    Attitudes and perceptions toward novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey
    The authors conducted a survey of stakeholders with experience and expertise in microbicide and HIV prevention clinical trials. They found that methods that require no additional input from the participant and no modifications to the existing ring product are viewed as more acceptable to trial participants and more feasible to implement in the field.
  • Published research
    CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts
    This article describes a Consolidated Standards of Reporting Trials (CONSORT) extension to the CONSORT 2010 Statement that addresses methodological issues specific to trials of nonpharmacologic treatments, such as surgery, rehabilitation or psychotherapy. To develop these materials, the authors reviewed published literature, surveyed authors and conducted a consensus meeting. This update should enable researchers who are writing journal articles to increase the transparency of their reports and the accuracy of trial result interpretations.